Nanologica Investor Relations Material
Latest events
Q1 2025
16 Apr, 2025
Q4 2024
14 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nanologica
Access all reports
Segment Data
Access more data
Net sales by
Geography
China
Turkey
U.S.
RoW
Expenses by
Financials
Nanologica AB, a nanotechnology company, develops nanoporous silica for applications in the life science industry. Its technology combines a biologically active component with nano-sized pores to improve the delivery of drugs and vaccines to the target via controlled release mechanisms. The company’s products include Nano-pillars and Nano-spheres that are used in various applications such as biological treatments, diagnostics, or therapeutic medicines, as well as drug formulations in pharmaceuticals and other industries. Nanologica AB was founded in 2004 and is based in Södertälje, Sweden.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NICA
Country
🇸🇪 Sweden